KU-55933: Potent and Selective ATM Kinase Inhibitor for DNA Damage Response Research

Executive Summary: KU-55933 is a highly selective inhibitor of the ATM kinase, with an IC50 of 13 nM and Ki of 2.2 nM, demonstrating robust selectivity over related kinases (APExBIO). The compound suppresses ATM-mediated phosphorylation of Akt at Ser473, thereby modulating DNA damage checkpoint signaling and cell survival pathways (Nature Communications, 2023). In cancer cell lines, KU-55933 induces G1 cell cycle arrest and inhibits proliferation by downregulating cyclin D1 levels. Metabolic profiling in MCF-7 cells reveals increased lactate production and glucose consumption, with concomitant ATP depletion, upon treatment with KU-55933. The compound is widely applied in studies of DNA damage response, genome stability, and cancer biology (HMN-214.com).

Biological Rationale

Ataxia-telangiectasia mutated (ATM) kinase is a master regulator of the DNA damage response (DDR) and coordinates cellular signaling following DNA double-strand breaks (DSBs). ATM phosphorylates key substrates involved in cell cycle control, DNA repair, and apoptosis. Deregulation of ATM activity is implicated in cancer development, neurodegeneration, and immune dysfunction (Nature Communications). Targeting ATM with potent inhibitors such as KU-55933 allows researchers to dissect DDR signaling, elucidate mechanisms of genome instability, and develop precision oncology approaches (PPACKDihydrochloride.com). This article extends the analysis of ATM inhibition beyond the foundational frameworks discussed in the above source by providing detailed, quantitative benchmarks and practical workflow guidance for KU-55933 deployment.

Mechanism of Action of KU-55933 (ATM Kinase Inhibitor)

KU-55933 is a small-molecule inhibitor that binds to the catalytic domain of human ATM kinase. The compound exhibits an IC50 of 13 nM and a Ki of 2.2 nM for ATM, confirming its high potency (APExBIO). Selectivity assays show that KU-55933 is over 100-fold more selective for ATM than for related PI3K-family kinases (PI3K, PI4K, ATR, mTOR, DNA-PK), with negligible off-target activity at concentrations below 1 μM (KU55933.com). ATM kinase mediates the phosphorylation of Akt at Ser473, a critical event in cell survival and proliferation signaling. KU-55933 blocks this phosphorylation, suppressing downstream Akt pathway activation. As a result, treated cells exhibit reduced cyclin D1 expression, G1 phase arrest, and decreased proliferation. ATM inhibition also alters metabolic flux, increasing glycolysis (as evidenced by lactate production and glucose uptake) and decreasing ATP content, especially in MCF-7 breast cancer cells (APExBIO).

Evidence & Benchmarks

• KU-55933 exhibits an ATM kinase IC50 of 13 nM and Ki of 2.2 nM, with >100-fold selectivity over DNA-PK, PI3K, PI4K, ATR, and mTOR (APExBIO).
• In MDA-MB-453 and PC-3 cancer cell lines, 10 μM KU-55933 induces ~50% inhibition of cell proliferation after 48 h exposure (Nature Communications, 2023).
• KU-55933 treatment increases lactate production and glucose consumption, with ATP levels decreased in MCF-7 cells (6 h, 10 μM) (Nature Communications, Fig. 3).
• ATM inhibition by KU-55933 blocks phosphorylation of Akt at Ser473 and downregulates cyclin D1, causing G1 cell cycle arrest (mTORinhibitor.com).
• KU-55933 is insoluble in water and ethanol but is soluble at ≥41.67 mg/mL in DMSO at room temperature with gentle warming (APExBIO).
• Stock solutions remain stable below -20°C for several months; recommended storage is desiccated at -20°C (APExBIO).
• Nuclear cGAS functions in genome integrity preservation via ATM signaling, which can be dissected using ATM inhibitors such as KU-55933 (Nature Communications, 2023).

Applications, Limits & Misconceptions

KU-55933 is applied in fundamental and translational research on DNA damage checkpoint signaling, cell cycle regulation, apoptosis, metabolic reprogramming, and cancer biology. Its use is prominent in models investigating the ATM signaling pathway, ataxia-telangiectasia, and genome stability. For example, studies leveraging KU-55933 (ATM Kinase Inhibitor) have revealed crosstalk between ATM and cGAS in regulating LINE-1 retrotransposition and cellular responses to genotoxic stress (Nature Communications, 2023). This article clarifies and updates the experimental boundaries and metabolic impacts described in previous work, focusing on precise workflow integration and critical storage parameters.

Common Pitfalls or Misconceptions

• Non-specific kinase inhibition: KU-55933 is highly selective for ATM but should not be assumed to inhibit unrelated kinases (e.g., CDKs, Aurora kinases) at effective concentrations (APExBIO).
• Solubility limitations: The compound is insoluble in water and ethanol; improper solvent use can result in precipitation and inconsistent dosing.
• Cell line variability: Not all cell lines are equally sensitive; some may require higher concentrations or show resistance due to alternate DDR pathways.
• Storage and stability: Long-term storage of solutions above -20°C or repeated freeze-thaw cycles can decrease activity.
• Interpretation of metabolic effects: Changes in ATP or lactate levels may reflect indirect effects of G1 arrest or metabolic rewiring, not just ATM inhibition.

Workflow Integration & Parameters

KU-55933 is supplied as a solid by APExBIO (SKU: A4605). Dissolve at ≥41.67 mg/mL in DMSO with gentle warming. Working concentrations for cellular assays typically range from 0.5 μM to 10 μM; higher concentrations may affect off-target kinases. For best results, prepare fresh solutions before use; stock solutions may be stored at -20°C for several months, protected from moisture (APExBIO). Functional readouts include immunoblotting for phospho-Akt (Ser473), cyclin D1, and cell proliferation assays. Researchers should confirm selectivity in their system, as some cancer models may have compensatory pathways. For expanded mechanistic frameworks, see Reimagining ATM Kinase Inhibition, which provides a systems-level perspective on ATM-cGAS interplay; the current article extends these findings by supplying actionable solubility, storage, and benchmarking protocols for KU-55933 deployment.

Conclusion & Outlook

KU-55933 remains a gold-standard tool for ATM kinase inhibition in DNA damage response and cancer research. Its high selectivity and robust cellular effects support diverse applications, from basic mechanistic studies to translational oncology. Proper solubility management, storage, and experimental controls are essential for reproducible results. Future research will benefit from integrating KU-55933 into multiplexed DDR and immune signaling models, especially those exploring the intersection of ATM, cGAS, and genome integrity (Nature Communications, 2023).